Contraception: latest news

Contraception resources

Contraception features

Contraception news from aidsmap

More news

Contraception news selected from other sources

  • S.Africa HIV-positive women forced to sterilise: rights groups

    Doctors at some public hospitals in South Africa have allegedly coerced dozens of HIV-positive women to undergo sterilisation over the past three decades, rights groups said Thursday.

    20 March 2015 | Yahoo News
  • The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest

    A newly published study is stirring up questions about the relationship between Depo-Provera, and other progestogen-only injectable contraceptives, and the risk of HIV acquisition among HIV-negative women. The study triggered a wave of headlines and tweets that boiled down the complexities and caveats of this analysis into an oversimplified statement: Depo increases women’s risk of HIV by 40 percent.

    14 January 2015 | RH Reality Check
  • Contraceptive injection raises risk of HIV, research warns

    Lancet analysis finds 40% increase in infection risk for women using birth control jab compared with other hormonal methods.

    09 January 2015 | The Guardian
  • PrEP works in women using injectable hormonal contraceptives and in their male sex partners

    Preexposure prophylaxis (PrEP) with tenofovir or tenofovir/emtricitabine proved as effective in women using the injectable hormonal contraceptive depot medroxyprogesterone acetate (DMPA) as in women using no hormonal contraceptive. The same proved true of men whose female sex partners were using DMPA.

    07 January 2015 | International AIDS Society
  • Can Women Living with HIV and Taking Antiretroviral Therapy Use Hormonal Contraceptive Methods?

    An increasingly important issue is whether certain ART regimens are expected to have drug interactions when used with certain hormonal contraceptive methods. In theory, an interaction could affect the efficacy of either medication, or cause side effects or toxicity. If contraceptive efficacy decreases, the chances of contraceptive failure, unintended pregnancy, and the accompanying consequences increase.

    10 December 2014 | K4Health
  • As strategies to prevent HIV and unintended pregnancies evolve, concepts of “multi-purpose technologies” raise a familiar question . . .

    What do women want? While two trials test vaginal rings to fight HIV, market research highlights respondents’ interests in different options.

    14 November 2014 | Science Speaks
  • Dissolving Tampons Deliver HIV Drugs (and Maybe Contraception, Too)

    University of Washington researchers have created a discreet, quick-dissolving tampon out of silk-line fibers to protect women from HIV. The researchers would ideally like to develop a tampon to protect against HIV, herpes, and pregnancy — an all-in-one shield against the risks of sex. This could prove especially useful in developing countries, where women may not have easy access to other kinds of birth control.

    04 November 2014 | Healthline News
  • Oral contraception may become renewed option for HIV-positive women

    Contrary to guidelines issued by the World Health Organization, new research has found that HIV-positive women receiving one of the most common forms of drug therapy should be able to use at least some forms of oral contraceptives for birth control.

    30 October 2014 | Oregon State University
  • PrEP, The Pill, and the Fear of Promiscuity

    LGBT academic Ian Lekus compares the furore around PrEP with the one that met the development of the contraceptive pill: "Acknowledged or not, PrEP users — and for that matter, three decades-plus of HIV/AIDS activism — build directly on how the Pill’s early adopters challenged the presumed omniscience of medical authorities. The experiences of the Pill’s first users also remind us to keep a critical eye trained on those institutions and narratives that circumscribe the quest for balancing health, desire, and autonomy."

    25 September 2014 | Nursing Clio
  • Advocates Call for Full Funding of Research on HIV and Contraception

    We call on the donors to ensure the ECHO trial is fully funded without additional budget cuts or delays. ECHO is a randomized clinical trial that would look at whether the three options—Depo, Jadelle, and the copper intrauterine device—affect HIV-negative women’s risk of acquiring HIV.

    15 September 2014 | RH Reality Check
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also